Cargando…
Recent advances in oridonin derivatives with anticancer activity
Cancer is a leading cause of mortality responsible for an estimated 10 million deaths worldwide in 2020, and its incidence has been rapidly growing over the last decades. Population growth and aging, as well as high systemic toxicity and chemoresistance associated with conventional anticancer therap...
Autores principales: | Sobral, Pedro J. M., Vicente, André T. S., Salvador, Jorge A. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947293/ https://www.ncbi.nlm.nih.gov/pubmed/36846854 http://dx.doi.org/10.3389/fchem.2023.1066280 |
Ejemplares similares
-
Structural modification of oridonin via DAST induced rearrangement
por: Luo, Dong-Dong, et al.
Publicado: (2018) -
Recent Advances of Gold Compounds in Anticancer Immunity
por: Yue, Shuang, et al.
Publicado: (2020) -
Design and synthesis of novel oridonin analogues as potent anticancer agents
por: Shen, Qing-Kun, et al.
Publicado: (2018) -
Therapeutic Potential of Oridonin and Its Analogs: From Anticancer and Antiinflammation to Neuroprotection
por: Xu, Jimin, et al.
Publicado: (2018) -
Editorial: Recent advances in the research and development of kinase-inhibitory anticancer molecules
por: Al-Karmalawy, Ahmed A., et al.
Publicado: (2023)